Persephone Biosciences: Funding, Investors & Team (Sep 2026)
Persephone Biosciences specializes in healthcare technology aimed at utilizing microbial therapeutics for immuno-oncology. By utilizing artificial intelligence and omics techniques on cancer patient samples, the company identifies beneficial microbes for immune function and conducts population-scale data analysis. This allows researchers to develop microbial drugs to combat cancer. Persephone Biosciences, founded in 2017, is located in San Diego, California.
Persephone Biosciences has raised $15.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Apr 2025.
Persephone Biosciences Company Profile and Key Stats
Latest funding round on record: Apr 2025.
Persephone Biosciences Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Persephone Biosciences raised $15.0M in a Seed announced in Jul 2022.
2.8 years later, an undisclosed round was announced in Apr 2025 with no disclosed amount.
Persephone Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Persephone Biosciences Funding Compared to Other Artificial Intelligence Startups
Funded Startups Like Persephone Biosciences in Artificial Intelligence and San Diego
Companies Similar to Persephone Biosciences
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Persephone Biosciences Funding FAQs
What does Persephone Biosciences do?
Persephone Biosciences specializes in healthcare technology aimed at utilizing microbial therapeutics for immuno-oncology. By utilizing artificial intelligence and omics techniques on cancer patient samples, the company identifies beneficial microbes for immune function and conducts population-scale data analysis. This allows researchers to develop microbial drugs to combat cancer. Persephone Biosciences, founded in 2017, is located in San Diego, California.
How much funding has Persephone Biosciences raised?
Persephone Biosciences has raised $15.0M across 2 rounds on record.
When did Persephone Biosciences last raise funding?
Persephone Biosciences' most recent funding round on record was announced in Apr 2025. The amount was not disclosed.
Who founded Persephone Biosciences?
FundedIQ lists Steve Van Dien (Founder) at Persephone Biosciences.
Who is the CEO of Persephone Biosciences?
Stephanie Culler is listed as CEO at Persephone Biosciences.
Where is Persephone Biosciences headquartered?
Persephone Biosciences is based in San Diego, California, United States.
How many employees does Persephone Biosciences have?
Persephone Biosciences is in the 11-50 employee band.
About FundedIQ's Persephone Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Persephone Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.